{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:59:05Z","timestamp":1783774745732,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11102-019-00939-x","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T09:40:00Z","timestamp":1547458800000},"page":"113-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3638-4224","authenticated-orcid":false,"given":"Yanyan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1632-5101","authenticated-orcid":false,"given":"Lu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4183-5560","authenticated-orcid":false,"given":"Xiaopeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3961-0100","authenticated-orcid":false,"given":"Zihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8023-5138","authenticated-orcid":false,"given":"Wei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9571-3705","authenticated-orcid":false,"given":"Kan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-8277","authenticated-orcid":false,"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3864-5168","authenticated-orcid":false,"given":"Bing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5172-6870","authenticated-orcid":false,"given":"Huijuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"939_CR1","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658\u20135671","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR2","doi-asserted-by":"publisher","first-page":"T119","DOI":"10.1530\/ERC-17-0199","volume":"24","author":"SK Agarwal","year":"2017","unstructured":"Agarwal SK (2017) The future: genetics advances in MEN1 therapeutic approaches and management strategies. Endocr Relat Cancer 24:T119\u2013Tt134","journal-title":"Endocr Relat Cancer"},{"key":"939_CR3","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1172\/JCI115720","volume":"89","author":"C Larsson","year":"1992","unstructured":"Larsson C, Shepherd J, Nakamura Y, Blomberg C, Weber G, Werelius B, Hayward N, Teh B, Tokino T, Seizinger B (1992) Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest 89:1344\u20131349","journal-title":"J Clin Invest"},{"key":"939_CR4","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (2012) Endocrine Society: Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990\u20133011","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1158\/1078-0432.CCR-0938-3","volume":"10","author":"B Asgharian","year":"2004","unstructured":"Asgharian B, Chen YJ, Patronas NJ, Peghini PL, Reynolds JC, Vortmeyer A, Zhuang Z, Venzon DJ, Gibril F, Jensen RT (2004) Meningiomas may be a component tumor of multiple endocrine neoplasia type 1. Clin Cancer Res 10:869\u2013880","journal-title":"Clin Cancer Res"},{"key":"939_CR6","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990\u20133011","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"MC Lemos","year":"2008","unstructured":"Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22\u201332","journal-title":"Hum Mutat"},{"key":"939_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1210\/edrv-8-4-391","volume":"8","author":"ML Brandi","year":"1987","unstructured":"Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA (1987) Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev 8:391\u2013405","journal-title":"Endocr Rev"},{"key":"939_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1530\/EJE-08-0153","volume":"159","author":"DM Lourenco Jr","year":"2008","unstructured":"Lourenco DM Jr, Toledo RA, Mackowiak II, Coutinho FL, Cavalcanti MG, Correia-Deur JE, Montenegro F, Siqueira SA, Margarido LC, Machado MC, Toledo SP (2008) Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile. Eur J Endocrinol 159:259\u2013274","journal-title":"Eur J Endocrinol"},{"key":"939_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/jc.2015-3766","volume":"101","author":"RS Leeuwaarde van","year":"2016","unstructured":"van Leeuwaarde RS, van Nesselrooij BP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, de Laat JM, Pieterman CR, Valk GD (2016) Impact of delay in diagnosis in outcomes in MEN1: results From the Dutch MEN1 Study Group. J Clin Endocrinol Metab 101:1159\u20131165","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR11","first-page":"2642","volume":"81","author":"JR Burgess","year":"1996","unstructured":"Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM (1996) Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred. J Clin Endocrinol Metab 81:2642\u20132646","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","volume":"58","author":"F Giusti","year":"2017","unstructured":"Giusti F, Cianferotti L, Boaretto F, Cetani F, Cioppi F, Colao A, Dav\u00ec MV, Faggiano A, Fanciulli G, Ferolla P, Ferone D, Fossi C, Giudici F, Gronchi G, Loli P, Mantero F, Marcocci C, Marini F, Masi L, Opocher G, Beck-Peccoz P, Persani L, Scillitani A, Sciortino G, Spada A, Tomassetti P, Tonelli F, Brandi ML (2017) Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database. Endocrine 58:349\u2013359","journal-title":"Endocrine"},{"key":"939_CR13","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1210\/JC.2015-2015","volume":"100","author":"JM Laat de","year":"2015","unstructured":"de Laat JM, Dekkers OM, Pieterman CR, Kluijfhout WP, Hermus AR, Pereira AM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, de Herder WW, Valk GD (2015) Long-term natural course of pituitary tumors in patients With MEN1: results from the DutchMEN1 Study Group (DMSG). J Clin Endocrinol Metab 100:3288\u20133296","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","volume":"87","author":"B Verges","year":"2002","unstructured":"Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C, Calender A (2002) Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 87:457\u2013465","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11102-013-0462-8","volume":"17","author":"VS Nunes","year":"2014","unstructured":"Nunes VS, Souza GL, Perone D, Conde SJ, Nogueira CR (2014) Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening. Pituitary 17:30\u201337","journal-title":"Pituitary"},{"key":"939_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","volume":"76","author":"A Sakurai","year":"2012","unstructured":"Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M, Uruno T, Horiuchi K, Miyauchi A, Imamura M, MEN Consortium of Japan, Fukushima T, Hanazaki K, Hirakawa S, Igarashi T, Iwatani T, Kammori M, Katabami T, Katai M, Kikumori T, Kiribayashi K, Koizumi S, Midorikawa S, Miyabe R, Munekage T, Ozawa A, Shimizu K, Sugitani I, Takeyama H, Yamazaki M (2012) Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin Endocrinol (Oxf) 76:533\u2013539","journal-title":"Clin Endocrinol (Oxf)"},{"key":"939_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10689-016-9891-7","volume":"15","author":"M Goroshi","year":"2016","unstructured":"Goroshi M, Bandgar T, Lila AR, Jadhav SS, Khare S, Shrikhande SV, Uchino S, Dalvi AN, Shah NS (2016) Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India. Fam Cancer 15:617\u2013624","journal-title":"Fam Cancer"},{"key":"939_CR18","first-page":"815","volume":"76","author":"JD Wilson","year":"1993","unstructured":"Wilson JD (1993) Peking Union Medical College Hospital, a palace of endocrine treasures. J Clin Endocrinol Metab 76:815\u2013816","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65:265\u2013273","journal-title":"Clin Endocrinol (Oxf)"},{"key":"939_CR20","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","volume":"16","author":"S Melmed","year":"2013","unstructured":"Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, Strasburger CJ, Wass JA, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16:294\u2013302","journal-title":"Pituitary"},{"key":"939_CR22","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A (2015) Treatment of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100:2807\u20132831","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR23","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1530\/EJE-16-0946","volume":"176","author":"JW Findling","year":"2017","unstructured":"Findling JW, Raff H (2017) DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic\/neoplastic hypercortisolism (Cushing\u2019s syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing\u2019s syndrome). Eur J Endocrinol 176:R205\u2013Rr216","journal-title":"Eur J Endocrinol"},{"key":"939_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solorzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151:959\u2013968","journal-title":"JAMA Surg"},{"issue":"Suppl 2","key":"939_CR25","doi-asserted-by":"crossref","first-page":"ii102","DOI":"10.1093\/annonc\/mdn116","volume":"19","author":"K Oberg","year":"2008","unstructured":"Oberg K, Jelic S, ESMO Guidelines Working Group (2008) Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up. Ann Oncol 19(Suppl 2):ii102\u2013i103","journal-title":"Ann Oncol"},{"issue":"Suppl 7","key":"939_CR26","doi-asserted-by":"crossref","first-page":"vii124","DOI":"10.1093\/annonc\/mds295","volume":"23","author":"K Oberg","year":"2012","unstructured":"Oberg K, Knigge U, Kwekkeboom D, Perren A, ESMO Guidelines Working Group (2012) Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii124\u2013130","journal-title":"Ann Oncol"},{"key":"939_CR27","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 175:G1\u2013Gg34","journal-title":"Eur J Endocrinol"},{"key":"939_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","volume":"76","author":"A Sakurai","year":"2012","unstructured":"Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M, Uruno T, Horiuchi K, Miyauchi A, Imamura M (2012) Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin Endocrinol 76:533\u2013539","journal-title":"Clin Endocrinol"},{"key":"939_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MPA.0000000000000987","volume":"47","author":"H Zhang","year":"2018","unstructured":"Zhang H, Han W, Jin M, Lai Y, Wang X, Wang J, Yao Y, Wu D, Qian J, Yang H (2018) Establishment and verification of a scoring model for the differential diagnosis of pancreatic cancer and chronic pancreatitis. Pancreas 47:459\u2013465","journal-title":"Pancreas"},{"key":"939_CR30","doi-asserted-by":"crossref","first-page":"71699","DOI":"10.18632\/oncotarget.17599","volume":"8","author":"JH Fan","year":"2017","unstructured":"Fan JH, Zhang YQ, Shi SS, Chen YJ, Yuan XH, Jiang LM, Wang SM, Ma L, He YT, Feng CY, Sun XB, Liu Q, Deloso K, Chi Y, Qiao YL (2017) A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in china. Oncotarget 8 71699\u201371708","journal-title":"Oncotarget"},{"key":"939_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1530\/EJE-13-0441","volume":"169","author":"G Han","year":"2013","unstructured":"Han G, Wang O, Nie M, Zhu Y, Meng X, Hu Y, Liu H, Xing X (2013) Clinical phenotypes of Chinese primary hyperparathyroidism patients are associated with the calcium-sensing receptor gene R990G polymorphism. Eur J Endocrinol 169:629\u2013638","journal-title":"Eur J Endocrinol"},{"key":"939_CR32","first-page":"651","volume":"46","author":"ST Yan","year":"2007","unstructured":"Yan ST, Tian H, Li CL, Zong WY, Shao YH, Zhong WW, Gong YP (2007) A preliminary survey of primary hyperparathyroidism in middle-aged and elderly Beijing Chinese. Zhonghua Nei Ke Za Zhi 46:651\u2013653","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"939_CR33","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1210\/jc.2004-1155","volume":"90","author":"P Ferolla","year":"2005","unstructured":"Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano G, Avenia N, Daddi G, Puma F, Ribacchi R, Santeusanio F, Angeletti G, Brandi ML (2005) Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 90:2603\u20132609","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR34","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/cen.13480","volume":"87","author":"L Ye","year":"2017","unstructured":"Ye L, Wang W, Ospina NS, Jiang L, Christakis I, Lu J, Zhou Y, Zhu W, Cao Y, Wang S, Perrier ND, Young WF Jr, Ning G, Wang W (2017) Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: a single-centre study, systematic review and meta-analysis. Clin Endocrinol (Oxf) 87:706\u2013716","journal-title":"Clin Endocrinol (Oxf)"},{"key":"939_CR35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/cen.13528","volume":"88","author":"E Brown","year":"2018","unstructured":"Brown E, Watkin D, Evans J, Yip V, Cuthbertson DJ (2018) Multidisciplinary management of refractory insulinomas. Clin Endocrinol 88:615\u2013624","journal-title":"Clin Endocrinol"},{"key":"939_CR36","first-page":"817","volume":"35","author":"A Faggiano","year":"2012","unstructured":"Faggiano A, Ferolla P, Grimaldi F, Campana D, Manzoni M, Davi MV, Bianchi A, Valcavi R, Papini E, Giuffrida D, Ferone D, Fanciulli G, Arnaldi G, Franchi GM, Francia G, Fasola G, Crino L, Pontecorvi A, Tomassetti P, Colao A (2012) Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. J Endocrinol Invest 35:817\u2013823","journal-title":"J Endocrinol Invest"},{"key":"939_CR37","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","volume":"32","author":"J Trouillas","year":"2008","unstructured":"Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Verges B, Chabre O, Calender A (2008) Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case\u2013control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol 32:534\u2013543","journal-title":"Am J Surg Pathol"},{"key":"939_CR38","first-page":"205","volume":"4","author":"BW Scheithauer","year":"1987","unstructured":"Scheithauer BW, Laws ER Jr, Kovacs K, Horvath E, Randall RV, Carney JA (1987) Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol 4:205\u2013211","journal-title":"Semin Diagn Pathol"},{"key":"939_CR39","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1210\/jcem-60-4-698","volume":"60","author":"ME Molitch","year":"1985","unstructured":"Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, Joplin G, Robbins RJ, Tyson J, Thorner MO (1985) Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study*. J Clin Endocrinol Metab 60:698\u2013705","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR40","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1210\/jc.2003-032180","volume":"89","author":"GD Hammer","year":"2004","unstructured":"Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB (2004) Transsphenoidal microsurgery for Cushing\u2019s disease: initial outcome and long-term results. J Clin Endocrinol Metab 89:6348\u20136357","journal-title":"J Clin Endocrinol Metab"},{"key":"939_CR41","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s11102-017-0813-y","volume":"20","author":"C Fernandez Mateos","year":"2017","unstructured":"Fernandez Mateos C, Garcia-Uria M, Morante TL, Garcia-Uria J (2017) Acromegaly: surgical results in 548 patients. Pituitary 20:522\u2013528","journal-title":"Pituitary"},{"key":"939_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2265.1996.00824.x","volume":"45","author":"WJ Jeffcoate","year":"1996","unstructured":"Jeffcoate WJ, Pound N, Sturrock ND, Lambourne J (1996) Long-term follow-up of patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 45:299\u2013303","journal-title":"Clin Endocrinol (Oxf)"},{"key":"939_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11102-017-0856-0","volume":"21","author":"W Huang","year":"2018","unstructured":"Huang W, Molitch ME (2018) Management of nonfunctioning pituitary adenomas (NFAs): observation. Pituitary 21 162\u2013167","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-019-00939-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T12:06:05Z","timestamp":1606046765000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-019-00939-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1007\/s11102-019-00939-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]},"assertion":[{"value":"14 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in accordance with the ethical standards of the Institutional Ethics Committee of Peking Union Medical College Hospital at the Chinese Academy of Medical Sciences & Peking Union Medical College and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written or verbal informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}